Viewing SEC Facts Units
Company Name:
Neuphoria Therapeutics Inc.
CIK:
1191070
Start Filing Date:
End Filing Date:
2023-06-30
ACCN:
0000950170-24-004818
Value:
$ 1,486,735,424
Value Error:
$ None
Created By:
Date Filed:
2024-01-17
FY:
2023
Fiscal Period:
FY
Frame:
CY2023Q2I
Type:
dei
Form:
20-F/A
Units:
shares